Li Zou

1.5k total citations
32 papers, 1.1k citations indexed

About

Li Zou is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cell Biology. According to data from OpenAlex, Li Zou has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Cell Biology. Recurrent topics in Li Zou's work include Neuroscience and Neuropharmacology Research (7 papers), Alzheimer's disease research and treatments (6 papers) and Cellular transport and secretion (6 papers). Li Zou is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Alzheimer's disease research and treatments (6 papers) and Cellular transport and secretion (6 papers). Li Zou collaborates with scholars based in China, United States and Sweden. Li Zou's co-authors include Jing Wu, Ling‐Qiang Zhu, Haifan Xiao, Hongjuan Sun, Zhentao Zhang, Vijay H. Shah, Robert C. Huebert, Lanxia Meng, Guifen Qiang and Lijun Dai and has published in prestigious journals such as Journal of Biological Chemistry, Neuroscience and Progress in Neurobiology.

In The Last Decade

Li Zou

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Zou China 16 423 176 168 147 143 32 1.1k
Magdalena Zielińska Poland 23 598 1.4× 139 0.8× 514 3.1× 371 2.5× 109 0.8× 71 1.7k
Natasha T. Snider United States 25 825 2.0× 148 0.8× 228 1.4× 206 1.4× 57 0.4× 50 2.1k
Santa Mammana Italy 19 476 1.1× 58 0.3× 227 1.4× 338 2.3× 57 0.4× 31 1.4k
Hongxia Chen China 21 471 1.1× 108 0.6× 264 1.6× 90 0.6× 46 0.3× 61 1.4k
Zhan Liu China 22 611 1.4× 111 0.6× 256 1.5× 205 1.4× 44 0.3× 57 1.8k
Alessandra Carcereri de Prati Italy 23 727 1.7× 92 0.5× 130 0.8× 167 1.1× 84 0.6× 42 2.0k
Yasuko Kitagishi Japan 23 1.0k 2.4× 226 1.3× 188 1.1× 299 2.0× 37 0.3× 55 1.9k
Y Liu China 21 497 1.2× 118 0.7× 152 0.9× 159 1.1× 53 0.4× 75 1.3k

Countries citing papers authored by Li Zou

Since Specialization
Citations

This map shows the geographic impact of Li Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zou more than expected).

Fields of papers citing papers by Li Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zou. The network helps show where Li Zou may publish in the future.

Co-authorship network of co-authors of Li Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Li Zou. A scholar is included among the top collaborators of Li Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Zou. Li Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jingyue, et al.. (2024). The role of synaptic protein NSF in the development and progression of neurological diseases. Frontiers in Neuroscience. 18. 1395294–1395294. 2 indexed citations
2.
Zhan, Xiping, et al.. (2023). Harmaline toxicity on dorsal striatal neurons and its role in tremor. NeuroToxicology. 99. 152–161.
3.
Yan, Lijuan, et al.. (2023). A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant. Pharmacogenomics and Personalized Medicine. Volume 16. 817–823.
4.
Meng, Lanxia, Li Zou, Min Xiong, et al.. (2022). A synapsin Ⅰ cleavage fragment contributes to synaptic dysfunction in Alzheimer's disease. Aging Cell. 21(5). e13619–e13619. 18 indexed citations
5.
Zou, Li, Xingyu Zhang, Min Xiong, et al.. (2021). Asparagine endopeptidase cleaves synaptojanin 1 and triggers synaptic dysfunction in Parkinson's disease. Neurobiology of Disease. 154. 105326–105326. 14 indexed citations
6.
Zou, Li, Ye Tian, & Zhentao Zhang. (2021). Dysfunction of Synaptic Vesicle Endocytosis in Parkinson’s Disease. Frontiers in Integrative Neuroscience. 15. 619160–619160. 23 indexed citations
7.
Xiong, Min, Li Zou, Lanxia Meng, et al.. (2021). A γ-adducin cleavage fragment induces neurite deficits and synaptic dysfunction in Alzheimer’s disease. Progress in Neurobiology. 203. 102074–102074. 8 indexed citations
8.
Zou, Li, Yingchao Xue, Michael S. Jones, et al.. (2017). The Effects of Quinine on Neurophysiological Properties of Dopaminergic Neurons. Neurotoxicity Research. 34(1). 62–73. 15 indexed citations
9.
Wang, Yao, et al.. (2012). Two new isospirostanol sapogenins from Reineckia carnea. Chinese Chemical Letters. 23(11). 1240–1242. 2 indexed citations
10.
Shi, Bo, Rong Yang, Xiaohui Wang, et al.. (2012). Inhibition of 5-HT3 receptors-activated currents by cannabinoids in rat trigeminal ganglion neurons. Journal of Huazhong University of Science and Technology [Medical Sciences]. 32(2). 265–271. 12 indexed citations
11.
Wu, Jing, Haifan Xiao, Hongjuan Sun, Li Zou, & Ling‐Qiang Zhu. (2012). Role of Dopamine Receptors in ADHD: A Systematic Meta-analysis. Molecular Neurobiology. 45(3). 605–620. 205 indexed citations
12.
Zou, Li, et al.. (2010). Effects of liquiritigenin treatment on the learning and memory deficits induced by amyloid β-peptide (25–35) in rats. Behavioural Brain Research. 210(1). 24–31. 36 indexed citations
13.
Zou, Li. (2008). A Comparative Analysis of the Effectiveness of Implementing 5S Management in Experimental Teaching Center. Research and Exploration in Laboratory.
14.
Zhou, Hong, Lian Guo, Li Zou, et al.. (2007). Anti-inflammatory activity of 21(α, β)-methylmelianodiols, novel compounds from Poncirus trifoliata Rafinesque. European Journal of Pharmacology. 572(2-3). 239–248. 40 indexed citations
15.
Skog, Sven, et al.. (2003). Determination of serum thymidine kinase 1 by anti-TK1 antibody A potential indicator for diagnoses of tumor and monitoring of therapy. Clinical Chemistry. 49. 100–101. 1 indexed citations
16.
Zou, Li. (2002). Effect of glycyrrhizin on CCl_4-induced liver cirrhosis and bone loss in mice. Zhongguo yaolixue tongbao. 1 indexed citations
17.
Zou, Li, et al.. (2002). The Half-Life of Thymidine Kinase 1 in Serum Measured by ECL Dot Blot: A Potential Marker for Monitoring the Response to Surgery of Patients with Gastric Cancer. The International Journal of Biological Markers. 17(2). 135–140. 22 indexed citations
18.
He, J, Kiyofumi Yamada, Li Zou, & Toshitaka Nabeshima. (2001). Spatial memory deficit and neurodegeneration induced by the direct injection of okadaic acid into the hippocampus in rats. Journal of Neural Transmission. 108(12). 1435–1443. 44 indexed citations
19.
He, Qianyu, et al.. (2000). The Clinical Significance of Thymidine Kinase 1 Measurement in Serum of Breast Cancer Patients Using Anti-TK1 Antibody. The International Journal of Biological Markers. 15(2). 139–146. 54 indexed citations
20.
Zou, Li, Kiyofumi Yamada, Masashi Sasa, & Toshitaka Nabeshima. (1999). Two phases of behavioral plasticity in rats following unilateral excitotoxic lesion of the hippocampus. Neuroscience. 92(3). 819–826. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026